About this trial
This study aims to detect the effect of sodium chloride 5% solution as an adjuvant treatment with antimicrobial therapy in treatment of bacterial infectious keratits and to assess whether NaCl 5% accelerates epithelial healing, improves microbial eradication, and enhances visual outcomes in bacterial infectious keratitis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinically diagnosed bacterial infectious keratitis
Positive corneal scraping or strong clinical suspicion of bacterial cause.
Ability to provide informed consent and attend follow-up visits
Disqualifiers
• Fungal, viral, or acanthamoeba keratitis.
Recent (<7 days) topical corticosteroid use.
Corneal perforation or impending perforation.
History of hypersensitivity to study agents.
Trial design
Parallel
Treatments tested in this trial
Sodium chloride 5% solution
DrugUse Sodium chloride 5% solution with usual anti microbial drugs
quinolones
DrugUse of usual topical anti microbial treatment only
Treatment groups
Trial outcomes
Primary outcomes
Control of infection
Improvement of manifestation according to rate of healing
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: